![Sample our Physical Sciences journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/110819/TOC-Subject-Sample-2021-Physical-Sciences.jpg"})
Triple reuptake inhibitors (TRIs) have been identified as possible alternative treatments for central nervous system disorders. A practical synthesis was investigated to access a potent TRI, (4-amino-3-chloro-phenyl)-((S)-2-isobutyl-pyrrlidin-2-yl)-methanone (1), starting from alkylation of D-proline. Improved routes to key intermediates are discussed and demonstrated by an expedient multigram production of 1.
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
